Ikarian Capital

Ikarian Capital is a long/short equity hedge fund manager focused on the therapeutics and biotechnology sub-sectors. The firm employs a long/short investment strategy, seeking investment opportunities in public and private markets. They aim to generate high, risk-adjusted returns uncorrelated to the broader market, primarily through a fundamental approach to identify investment opportunities in the biotechnology and pharmaceutical sub-sectors. The Adviser seeks to construct a portfolio of high conviction ideas with asymmetric risk/reward payoffs.